Literature DB >> 16901423

Adolescents' perception of epilepsy compared with other chronic diseases: "through a teenager's eyes".

Christina Cheung1, Elaine Wirrell.   

Abstract

Adolescent perception of physical and social impact of chronic illness was assessed to determine (1) if there is greater prejudice toward epilepsy than other chronic disease and (2) if adolescents with chronic disease have less prejudice toward similarly affected peers with all types of chronic disease or just their specific chronic disease. Cognitively normal teens aged 13 to 18 years without chronic disease (n = 41) and with epilepsy (n = 32), asthma (n = 38), diabetes (n = 21), and migraine (n = 17) were interviewed in the outpatient clinics of a tertiary care pediatric center regarding their perceptions of the physical and social impact of eight chronic diseases (epilepsy, asthma, diabetes, Down syndrome, arthritis, migraine, leukemia, human immunodeficiency virus [HIV] infection). Epilepsy was perceived to have a more adverse physical impact than all chronic illnesses except Down syndrome. The perception was that it more frequently caused mental handicap, injured the afflicted individual and bystanders, and led to death. Epilepsy was also perceived to have a more negative social impact, particularly on behavior, honesty, popularity, adeptness at sports, and fun. Significantly more adolescents expressed reluctance to befriend peers with epilepsy, both from their own and their perceived parental perspectives. Having a chronic disease did not generally alter the adolescents' perceptions of peers with chronic disease. However, cases with epilepsy ranked this disease to have less social impact than teens with other chronic diseases. In conclusion, adolescents consider epilepsy to have a greater physical and social impact than most chronic diseases. Educational efforts should focus on the "normality" of most persons with epilepsy and emphasize the low risk of injury when proper first aid is followed.

Entities:  

Mesh:

Year:  2006        PMID: 16901423     DOI: 10.2310/7010.2006.00053

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  Seizure and Psychosocial Outcomes of Childhood and Juvenile Onset Generalized Epilepsies: Wolf in Sheep's Clothing, or Well-Dressed Wolf?

Authors:  Katherine Nickels
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

2.  A model for internalized stigma in children and adolescents with epilepsy.

Authors:  Joan K Austin; Susan M Perkins; David W Dunn
Journal:  Epilepsy Behav       Date:  2014-05-24       Impact factor: 2.937

3.  Experiences, expectations, and fears of adolescents with epilepsy or bronchial asthma.

Authors:  Susanne Marie Fisch; Martina Patrizia Neininger; Freerk Prenzel; Matthias Karl Bernhard; Frauke Hornemann; Andreas Merkenschlager; Wieland Kiess; Thilo Bertsche; Astrid Bertsche
Journal:  Eur J Pediatr       Date:  2018-07-03       Impact factor: 3.183

4.  Cognitive disorders in childhood epilepsy: a comparative longitudinal study using administrative healthcare data.

Authors:  Anna-Lisa Sorg; Rüdiger von Kries; Ingo Borggraefe
Journal:  J Neurol       Date:  2022-02-15       Impact factor: 6.682

Review 5.  Epilepsy: addressing the transition from pediatric to adult care.

Authors:  Seetha Rajendran; Anand Iyer
Journal:  Adolesc Health Med Ther       Date:  2016-06-27

Review 6.  Subtle Brain Developmental Abnormalities in the Pathogenesis of Juvenile Myoclonic Epilepsy.

Authors:  Maxime Gilsoul; Thierry Grisar; Antonio V Delgado-Escueta; Laurence de Nijs; Bernard Lakaye
Journal:  Front Cell Neurosci       Date:  2019-09-27       Impact factor: 5.505

7.  Cognitive performance and behavior across idiopathic/genetic epilepsies in children and adolescents.

Authors:  Frederik Jan Moorhouse; Sonia Cornell; Lucia Gerstl; Moritz Tacke; Timo Roser; Florian Heinen; Michaela Bonfert; Celina von Stülpnagel; Matias Wagner; Ingo Borggraefe
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.